Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

BASF reveals NMDA and AMPA antagonists

Aug. 23, 1996

UPF-596 described as a novel glutamate antagonist

Aug. 23, 1996

Study of senile plaques guide Alzheimer's development

Aug. 23, 1996

Study indicates that estrogen may delay Alzheimer's disease onset

Aug. 23, 1996

Biogen signs Avonex distribution agreements

Aug. 23, 1996

Positive study results reported for CytoTherapeutics' encapsulated hCNTF device

Aug. 23, 1996

5-HT1D antagonists claimed by SmithKine Beecham

Aug. 23, 1996

Allelix describes dopamine D4 ligands for schizophrenia

Aug. 23, 1996

Zeneca files for U.K. marketing approval for Seroquel

Aug. 23, 1996

Allelix Biopharmaceuticals reports selective M1/M2 receptor ligands

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...